Elie G. Dib

Polypharmacy, Potentially Inappropriate Medications, and Drug-Drug Interactions in Vulnerable Older Adults With Advanced Cancer Initiating Cancer Treatment

Erika Ramsdale, Mostafa Mohamed, Veronica Yu et al. · The Oncologist · 2022 · 86 citations · Full text

Medicine, Geriatric Medicine, Oncology +17

Palbociclib in Patients With Non–Small-Cell Lung Cancer With <i>CDKN2A</i> Alterations: Results From the Targeted Agent and Profiling Utilization Registry Study

Eugene R. Ahn, Pam K. Mangat, Elizabeth Garrett‐Mayer et al. · JCO Precision Oncology · 2020 · 69 citations

Medicine, Oncology, Pharmacology +16

Active Monitoring With or Without Endocrine Therapy for Low-Risk Ductal Carcinoma In Situ

E. Shelley Hwang, Terry Hyslop, Thomas Lynch et al. · JAMA · 2024 · 69 citations · Full text

Medicine, Oncology, Surgery +17

Phase II study of dichloroacetate, an inhibitor of pyruvate dehydrogenase, in combination with chemoradiotherapy for unresected, locally advanced head and neck squamous cell carcinoma

Steven Powell, Miroslaw Mazurczak, Elie G. Dib et al. · Investigational New Drugs · 2022 · 56 citations · Full text

Medicine, Oncology, Pharmacology +14

Concurrent Chemoradiation ± Atezolizumab (atezo) in Limited-Stage Small Cell Lung Cancer (LS-SCLC): Results of NRG Oncology/Alliance LU005

Kyndra S. Higgins, Chengping Hu, Helen J. Ross et al. · International Journal of Radiation Oncology*Biology*Physics · 2024 · 52 citations · Full text

Medicine, Oncology, Pharmacotherapy +16